Brief Report - (2025) Volume 14, Issue 6
Received: 31-Oct-2025, Manuscript No. jmmd-26-184707;
Editor assigned: 03-Nov-2025, Pre QC No. P-184707;
Reviewed: 17-Nov-2025, QC No. Q-184707;
Revised: 21-Nov-2025, Manuscript No. R-184707;
Published:
28-Nov-2025
, DOI: 10.37421/2161-0703.2025.14.551
Citation: Kim, Hana. ”Intestinal Parasitic Infections: Diagnosis, Control, and Future.” J Med Microb Diagn 14 (2025):551.
Copyright: © 2025 Kim H. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution and reproduction in any medium, provided the original author and source are credited.
Intestinal parasitic infections (IPIs) represent a substantial and ongoing global health challenge, particularly affecting individuals in resource-limited settings where their impact on both morbidity and cognitive development is profound [1].
The varying prevalence of IPIs across diverse geographical regions and demographic groups necessitates the development and implementation of tailored diagnostic approaches [1].
Current diagnostic methodologies encompass a spectrum from traditional microscopy to advanced molecular techniques, each offering distinct advantages and facing inherent limitations [1].
Molecular diagnostics, in particular, have emerged as transformative tools, providing enhanced sensitivity and specificity for IPI detection, thereby enabling precise identification of parasite species which is critical for effective treatment strategies and robust epidemiological surveillance [1].
Advances in rapid diagnostic tests are also playing a crucial role in improving the accessibility and speed of diagnosis in point-of-care settings [1].
The persistent burden of soil-transmitted helminths (STHs) and protozoa continues to affect millions of individuals worldwide, with children being disproportionately vulnerable to their detrimental effects [2].
An updated epidemiological overview of common intestinal parasites in Southeast Asia reveals a higher prevalence of specific helminths within rural agricultural communities, underscoring the need for localized public health interventions [2].
This highlights the importance of integrated control programs that judiciously combine mass drug administration with improvements in sanitation and comprehensive health education to achieve a sustainable reduction in IPIs [2].
Molecular diagnostic tools, including real-time PCR and LAMP assays, are significantly enhancing the accuracy and expediency with which intestinal parasitic infections are diagnosed [3].
Research evaluating novel multiplex real-time PCR assays demonstrates their superior sensitivity and specificity in the simultaneous detection of multiple common intestinal protozoa in stool samples when compared to traditional microscopy [3].
These advancements are paving the way for more efficient and reliable diagnostic workflows in clinical laboratories [3].
The correct and timely diagnosis of intestinal parasitic infections is of paramount importance for the effective management of individual patients and for the successful implementation of public health interventions [4].
Challenges associated with interpreting microscopic results for parasitic ova and larvae, influenced by factors such as sample quality and technician expertise, are well-documented [4].
To overcome these limitations and bolster diagnostic confidence, there is a strong advocacy for the standardization of laboratory procedures and the judicious integration of molecular methods [4].
The global prevalence of common soil-transmitted helminths such as Ascaris lumbricoides, Trichuris trichiura, and hookworm infections exhibits considerable variation, influenced by environmental factors like climate and socioeconomic determinants including sanitation [5].
Studies investigating the prevalence of these major STHs in specific rural communities, such as Nigeria, identify high-risk groups and provide crucial data for informing targeted deworming strategies [5].
Giardiasis, a common waterborne protozoan infection caused by Giardia duodenalis, can lead to significant gastrointestinal illness [6].
Research exploring the diagnostic utility of antigen detection assays for Giardia, when compared to traditional stool microscopy and molecular methods, highlights their potential for rapid and sensitive diagnosis in various clinical settings [6].
Cryptosporidiosis, another significant cause of diarrheal disease primarily affecting immunocompromised individuals, is caused by Cryptosporidium species [7].
A review of the current diagnostic landscape for cryptosporidiosis emphasizes the considerable advantages offered by immunofluorescence assays and molecular techniques over conventional methods for achieving accurate identification and species determination, which is critical for optimal patient management [7].
The increasing prevalence of drug resistance in intestinal parasites presents a formidable threat to the ongoing efficacy of established treatment regimens [8].
This concern necessitates a discussion of emerging patterns of anthelmintic resistance in both soil-transmitted helminths and protozoa, underscoring the urgent requirement for integrated strategies [8].
Such strategies must encompass robust surveillance of resistance, the development of novel therapeutic agents, and the enhancement of diagnostic tools for monitoring treatment effectiveness [8].
Entamoeba histolytica, the causative agent of amebiasis, remains a primary contributor to parasitic diseases associated with significant morbidity and mortality, particularly in developing nations [9].
The evaluation of novel point-of-care diagnostic tests for Entamoeba histolytica antigen in stool samples aims to improve diagnostic accessibility and speed, especially in resource-limited environments and during outbreak scenarios [9].
The impact of intestinal parasitic infections on child development and overall health is substantial and far-reaching [10].
Synthesizing recent evidence on the long-term consequences of early-life IPIs, including impaired growth, cognitive deficits, and heightened susceptibility to other infections, emphasizes the critical role of effective diagnosis and timely intervention [10].
These measures are essential for mitigating adverse outcomes and fostering healthy development in affected children [10].
Intestinal parasitic infections (IPIs) continue to pose a significant global health challenge, particularly in resource-limited settings where they profoundly affect morbidity and cognitive development [1].
The geographical and demographic variations in IPI prevalence underscore the necessity for precisely tailored diagnostic strategies [1].
Current diagnostic methods span traditional microscopy to sophisticated molecular techniques, each with its own set of strengths and weaknesses [1].
Molecular diagnostics, characterized by their enhanced sensitivity and specificity, are revolutionizing IPI detection, allowing for precise parasite species identification crucial for effective treatment and epidemiological monitoring [1].
Furthermore, advancements in rapid diagnostic tests are improving the accessibility and speed of diagnosis at the point-of-care [1].
The substantial burden of soil-transmitted helminths (STHs) and protozoa continues to impact millions globally, with children being especially vulnerable [2].
An updated epidemiological overview of common intestinal parasites in Southeast Asia reveals a higher prevalence of certain helminths in rural agricultural communities, highlighting the need for region-specific control measures [2].
This emphasizes the importance of integrated control programs that combine mass drug administration with enhanced sanitation and health education to sustainably reduce IPIs [2].
Molecular diagnostic tools, such as real-time PCR and LAMP assays, are significantly improving the accuracy and speed of diagnosing intestinal parasitic infections [3].
Research evaluating a novel multiplex real-time PCR assay for the simultaneous detection of multiple common intestinal protozoa in stool samples demonstrates its superior sensitivity and specificity compared to traditional microscopy [3].
These developments are paving the way for more efficient diagnostic workflows [3].
The correct and timely diagnosis of intestinal parasitic infections is paramount for effective patient management and public health interventions [4].
The interpretation of microscopy results for parasitic ova and larvae presents challenges, influenced by sample quality and technician expertise [4].
To overcome these limitations and enhance diagnostic confidence, there is a growing advocacy for standardizing laboratory procedures and integrating molecular methods [4].
The prevalence of major soil-transmitted helminths, including Ascaris lumbricoides, Trichuris trichiura, and hookworm infections, varies considerably worldwide, influenced by factors such as climate and sanitation [5].
Studies investigating the prevalence of these helminths in specific rural communities, like one in Nigeria, help identify high-risk groups and inform targeted deworming strategies [5].
Giardiasis, a common waterborne protozoan infection caused by Giardia duodenalis, can lead to significant gastrointestinal illness [6].
The diagnostic utility of antigen detection assays for Giardia is being explored in comparison to traditional stool microscopy and molecular methods, highlighting their potential for rapid and sensitive diagnosis in clinical settings [6].
Cryptosporidiosis, caused by Cryptosporidium species, is a notable cause of diarrheal disease, particularly in immunocompromised individuals [7].
A review of current diagnostic methodologies for cryptosporidiosis emphasizes the advantages of immunofluorescence assays and molecular techniques over conventional methods for accurate identification and species determination, which is crucial for patient management [7].
The rising incidence of drug resistance in intestinal parasites poses a significant threat to the effectiveness of current treatment regimens [8].
This review discusses the emerging patterns of anthelmintic resistance in soil-transmitted helminths and protozoa, underscoring the urgent need for integrated strategies that include robust resistance surveillance, development of new drugs, and improved diagnostic tools for monitoring treatment efficacy [8].
Entamoeba histolytica remains a leading cause of amebiasis, a parasitic disease associated with substantial morbidity and mortality, especially in developing countries [9].
This study evaluates a novel point-of-care diagnostic test for Entamoeba histolytica antigen in stool samples, aiming to enhance accessibility and speed of diagnosis in resource-limited settings and during outbreaks [9].
The profound impact of intestinal parasitic infections on child development and overall health is well-established [10].
A review synthesizing recent evidence on the long-term consequences of early-life IPIs, including impaired growth and cognitive deficits, highlights the critical role of effective diagnosis and timely treatment in mitigating these adverse outcomes and promoting healthy development [10].
Intestinal parasitic infections (IPIs) remain a major global health concern, particularly in resource-limited areas, affecting morbidity and cognitive development. Diagnosis has evolved from traditional microscopy to highly sensitive and specific molecular techniques, with rapid tests improving point-of-care accessibility. Soil-transmitted helminths and protozoa continue to impact millions, especially children, necessitating integrated control programs combining mass drug administration with sanitation and education. Advanced molecular diagnostics like real-time PCR are enhancing accuracy and speed. Microscopy challenges are being addressed by standardizing procedures and incorporating molecular methods. Prevalence studies inform targeted interventions. Diagnostic assays for Giardia and Cryptosporidium are improving. Drug resistance is a growing threat, requiring new strategies and improved diagnostics. Point-of-care tests for Entamoeba histolytica aim to increase accessibility. Early-life IPIs have long-term consequences on development, emphasizing the importance of timely diagnosis and treatment.
None
None
Medical Microbiology & Diagnosis received 14 citations as per Google Scholar report
